Items tagged with Access
Open letters to Johnson & Johnson requesting equitable access to bedaquiline (post with simple image)
Ukraine, Belarus, Azerbaijan and Moldova demand that Johnson & Johnson take urgent action to improve equitable access to bedaquiline in all countries with a high burden of TB.
Johnson & Johnson confirms intent not to enforce patents for SIRTURO® (bedaquiline) for the treatment of multidrug-resistant TB in 134 low- and middle-income countries (post with simple image)
The decision is intended to assure current and future generic manufacturers that they may manufacture and sell generic versions of SIRTURO® without a concern that the Company will enforce its bedaquiline patents, provided the generic versions of SIRTURO® are of good quality, medically acceptable, and are used only in the 134 low- and middle-income countries.
Johnson & Johnson pricing agreement for critical TB drug still unfairly restricts access in countries where the need is greatest (post with simple image)
Unitaid calls on Johnson & Johnson to drop secondary patents for the drug-resistant TB medicine bedaquiline, and to make negotiated rates with the Stop TB Partnership’s Global Drug Facility available to all countries, regardless of how they purchase drugs.
Activism delivers unprecedented victories in TB testing and treatment access (post with simple image)
Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.
An Activist’s Guide to Shorter Treatment for Drug-Resistant TB (post with simple image)
This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.
Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)
Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.
Addressing the needs of people with extensively drug-resistant TB through pre-approval access to drugs and research (post with simple image)
A viewpoint, published in Public Health Action, advocates for transparent, accessible pre-approval access as a core element of person-centered care for drug-resistant TB.
Stop TB Partnership announces the Legal Environment and Human Rights Scorecard (post with simple image)
The Scorecard aims to enhance visibility and multisectoral accountability regarding legal, policy and human rights barriers experienced by people affected by TB.
Call to Action: Shorter and more effective treatment for all people suffering from drug-resistant TB (post with simple image)
Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.
Lindsay McKenna: What does it mean to be a good activist? (post with simple image)
At the 2023 Union Conference, TAG's Lindsay McKenna sat down with Denis Godlevsky of ITPC EECA for a wide-ranging discussion on TB research, activism, and TAG's historic + present role shaping both.
Page 81 of 83 · Total posts: 0
←First 80 81 82 Last→